Showing results (1031-1040 of 1,172) with videos related to

Sort By:
Pageof 118
European Journal of Cancer (Oxford, England : 1990)|May 22, 2026
Debio 0123, a WEE1 kinase inhibitor: Phase 1 results from dose escalation in patients with advanced solid tumorsKyriakos P Papadopoulos, Manish R Sharma, Reinhard Dummer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2013
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantationAbhishek Singla, William J Hogan, Stephen M Ansell, et al.
Therapie|March 10, 2015
What strategy should France implement for H2020?Jean-François Dhainaut, Vincent Diebolt, Brigitte Pouletty-Lefèbvre, et al.
Blood|February 4, 2016
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institutionSaad Sirop Kenderian, Thomas M Habermann, William R Macon, et al.
Blood|April 30, 2015
The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphomaThomas E Witzig, Craig Reeder, Jing Jing Han, et al.
Plos One|July 26, 2012
HIV-1 infection and first line ART induced differential responses in mitochondria from blood lymphocytes and monocytes: the ANRS EP45 "Aging" studySophie Perrin, Jonathan Cremer, Patrice Roll, et al.
Journal of Structural and Functional Genomics|April 8, 2011
The Structural Biology Knowledgebase: a portal to protein structures, sequences, functions, and methodsMargaret J Gabanyi, Paul D Adams, Konstantin Arnold, et al.
BMC Psychiatry|April 20, 2019
SMS SOS: a randomized controlled trial to reduce self-harm and suicide attempts using SMS text messagingGarry J Stevens, Trent E Hammond, Suzanne Brownhill, et al.
Stem Cell Reports|June 18, 2014
FOXN1 (GFP/w) reporter hESCs enable identification of integrin-β4, HLA-DR, and EpCAM as markers of human PSC-derived FOXN1(+) thymic epithelial progenitorsChew-Li Soh, Antonietta Giudice, Robert A Jenny, et al.
British Journal of Haematology|August 3, 2021
Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analysesDaniel J Landsburg, Stefan K Barta, Radhakrishnan Ramchandren, et al.
Pageof 118